Fingerprint
Dive into the research topics of 'Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically